Skip to main content
. 2019 Feb 7;11(2):194. doi: 10.3390/cancers11020194

Figure 5.

Figure 5

Kaplan–Meier overall survival (OS) and progression-free survival (PFS) curves of GBM patients, based on the expression of circSMARCA5. Patients having a lower expression of circSMARCA5 (DCt ≥ Median DCt) survive less (A) show a shorter PFS (B) than patients with a higher expression of circSMARCA5 (DCt < Median DCt).